Markets:

Overview

News

Currencies

International

Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

886.46 +3.98 (+0.45%)

Delayed Quote Updated: 2:12 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

argenx Announces Results of Annual General Meeting of Shareholders

May 28, 2025

From argenx SE

Via GlobeNewswire

With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around? ↗

May 27, 2025

HC Wainwright upgrades Kyverna to Buy with a $5 target, citing upcoming trial data and a strong cash position that supports a runway into 2027.

Via Benzinga

This Caterpillar Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

May 13, 2025

Via Benzinga

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? ↗

May 11, 2025

The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio?

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

A Look Into argenx Inc's Price Over Earnings ↗

May 07, 2025

Via Benzinga

P/E Ratio Insights for argenx ↗

April 29, 2025

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today ↗

May 09, 2025

Via Benzinga

14 Analysts Have This To Say About argenx ↗

May 09, 2025

Via Benzinga

Argenx Shares Drop After Q1 Miss, But Retail Traders Call Sub-$550 ‘An Absolute Steal’ ↗

May 08, 2025

Despite the Q1 miss, management reiterated confidence in its long-term “Vision 2030” strategy, highlighting strong Vyvgart uptake in gMG and CIDP and the recent U.S. approval of a self-injection...

Via Stocktwits

Topics Earnings

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings ↗

May 08, 2025

Via Benzinga

Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble ↗

May 08, 2025

The company's drug treats two autoimmune conditions and recently launched with a prefilled synringe for at-home treatment.

Via Investor's Business Daily

What's Driving the Market Sentiment Around argenx? ↗

April 21, 2025

Via Benzinga

argenx Reports First Quarter 2025 Financial Results and Provides Business Update

May 08, 2025

From argenx SE

Via GlobeNewswire

argenx to Present at BofA Securities 2025 Health Care Conference

May 06, 2025

From argenx SE

Via GlobeNewswire

argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025

May 01, 2025

From argenx SE

Via GlobeNewswire

argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

April 28, 2025

From argenx SE

Via GlobeNewswire

Does ARGENX SE - ADR (NASDAQ:ARGX) meet the Minervini criteria? ↗

April 26, 2025

A fundamental and technical analysis of (NASDAQ:ARGX): Is ARGENX SE - ADR (NASDAQ:ARGX) suited for high growth investing?

Via Chartmill

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗

April 21, 2025

Via Benzinga

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

April 18, 2025

Via Benzinga

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting ↗

April 11, 2025

FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.

Via Benzinga

argenx Announces Annual General Meeting of Shareholders on May 27, 2025

April 11, 2025

From argenx SE

Via GlobeNewswire

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug ↗

April 11, 2025

The prefilled syringe will cost 4% more than the under-the-skin shot.

Via Investor's Business Daily

What 11 Analyst Ratings Have To Say About argenx ↗

April 11, 2025

Via Benzinga

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket ↗

April 11, 2025

Via Benzinga

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

April 10, 2025

From argenx SE

Via GlobeNewswire

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline ↗

April 09, 2025

Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs.

Via Benzinga

Topics Government Supply Chain World Trade

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients ↗

April 08, 2025

Argenx reports long-term Vyvgart data showing lasting efficacy in gMG and CIDP, with strong safety and symptom control across multiple studies.

Via Benzinga

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP

April 08, 2025

From argenx SE

Via GlobeNewswire

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

March 31, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

argenx SE - American Depositary Shares (NQ:ARGX)

All News about argenx SE - American Depositary Shares

Resources